Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger hair loss conditions like alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Excimer laser therapy can be an alternative for treating superficial morphea when topical steroids don't work.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

New medications could improve treatment for severe alopecia areata in Australia.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Skin problems after waxing led to a sarcoidosis diagnosis.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Topical treatment improved rare scalp lichen amyloidosis.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Araliadiol may help reduce skin aging and inflammation without killing cells.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

A young girl with skin and scalp conditions showed some improvement with treatment.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.